S. Saiagh

发表

Vaccination to improve the persistence of CD19CAR gene-modified T cells in relapsed pediatric acute lymphoblastic leukemia

A. Hackshaw, P. Veys, B. Dréno, 2017, Leukemia.

Tissue Biomarkers in Melanoma Patients Treated with TIL

B. Dréno, A. Khammari, G. Quéreux, 2012, PloS one.

Absence of amplification of CD4+CD25high regulatory T cells during in vitro expansion of tumor‐infiltrating lymphocytes in melanoma patients

C. Volteau, A. Khammari, F. Lemaı̂tre, 2008, Experimental dermatology.

Phase I/II clinical trial of adoptive cell transfer of sorted specific T cells for metastatic melanoma patients

B. Dréno, V. Vignard, A. Khammari, 2021, Cancer Immunology, Immunotherapy.

Reactivation of human herpesvirus 6 during ex vivo expansion of circulating CD34+ haematopoietic stem cells.

D. Boutolleau, S. Billaudel, N. Milpied, 2004, The Journal of general virology.

Effects of PGE2 upon differentiation and programmed cell death of suspension cultured CD4-CD8- thymocytes.

D. Rigal, J. Monier, S. Saiagh, 1994, International journal of immunopharmacology.

Induction of apoptosis in mouse thymocytes by cyclosporin A: an in vitro study.

C. Auger, J. Monier, N. Fabien, 1994, Immunopharmacology and immunotoxicology.

Fetal Fibroblasts and Keratinocytes with Immunosuppressive Properties for Allogeneic Cell-Based Wound Therapy

B. Dréno, A. Knol, J. Esbelin, 2013, PloS one.

CICAFAST: comparison of a biological dressing composed of fetal fibroblasts and keratinocytes on a split-thickness skin graft donor site versus a traditional dressing: a randomized controlled trial

B. Dréno, F. Duteille, A. Khammari, 2019, Trials.

A phase I/II feasibility vaccine study by autologous leukemic apoptotic corpse-pulsed dendritic cells for elderly AML patients

P. Chevallier, M. Béné, B. Dréno, 2021, Human vaccines & immunotherapeutics.

Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma

M. Rimbert, I. Philip, E. Bompas, 2008, Cancer Immunology, Immunotherapy.

Large scale expansion of ?9d2 T lymphocytes: Innacell ?d cell therapy product

C. Laplace, B. Dréno, F. Romagné, 2007 .

Treatment of metastatic melanoma with autologous Melan-A/MART-1-specific cytotoxic T lymphocyte clones.

B. Dréno, V. Vignard, A. Khammari, 2009, The Journal of investigative dermatology.

Tumor infiltrating lymphocytes as adjuvant treatment in stage III melanoma patients with only one invaded lymph node after complete resection: results from a multicentre, randomized clinical phase III trial

B. Dréno, A. Khammari, N. Labarrière, 2020, Cancer Immunology, Immunotherapy.

Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients

C. Volteau, B. Dréno, N. Basset-Seguin, 2018, Journal of immunology research.

Adoptive T cell therapy combined with intralesional administrations of TG1042 (adenovirus expressing interferon-γ) in metastatic melanoma patients

B. Dréno, J. Limacher, A. Khammari, 2015, Cancer Immunology, Immunotherapy.

New chondrosarcoma cell lines and mouse models to study the link between chondrogenesis and chemoresistance

M. Heymann, M. Denis, D. Heymann, 2013, Laboratory Investigation.

A Full GMP Process to Select and Amplify Epitope-Specific T Lymphocytes for Adoptive Immunotherapy of Metastatic Melanoma

B. Dréno, A. Khammari, F. Lang, 2013, Clinical & developmental immunology.